Skip to main content
Fig. 1 | BMC Musculoskeletal Disorders

Fig. 1

From: No difference in the incidence or location of deep venous thrombosis according to use of pharmacological prophylaxis following total knee arthroplasty

Fig. 1

Flowchart showing the retrospectively identified cohort of patients who underwent primary TKA at our institution and the reasons for exclusion. A total of 50 knees in patients who received anticoagulants and/or antiplatelet agents or who had a history of VTE were excluded, as were 10 knees in patients with a history of VTE or bleeding risk. TKA, total knee arthroplasty; VTE, venous thromboembolism

Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us